SCHEMBL6087168

SCHEMBL6087168

Nc1cnn(-c2nc(-c3ccccc3)c(Cl)nc2-c2ccccc2)c1N

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.42
PKM P14618 1/20 0.42
ALDH1A1 P00352 2/20 0.40
GLA P06280 2/20 0.40
HPGD P15428 2/20 0.40
LMNA P02545 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
HTT P42858 1/20 0.39
NPC1 O15118 5/20 0.39
RAB9A P51151 5/20 0.39
ATM Q13315 1/20 0.38
TP53 P04637 1/20 0.35
PTGS1 P23219 1/20 0.35
PTGS2 P35354 1/20 0.35
GAA P10253 1/20 0.35
ADORA2A P29274 4/20 0.34
ADORA1 P30542 4/20 0.34
XDH P47989 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27316158 0.72 KDM4E (0.74) KDM4EPKMALDH1A1GLAHPGD
SCHEMBL20600830 0.69 KDM4E (0.59) KDM4EPKMALDH1A1GLAHPGD
SCHEMBL23430737 0.68 KDM4E (0.68) KDM4EPKMALDH1A1GLAHPGD
SCHEMBL30838817 0.68 KDM4E (0.68) KDM4EPKMALDH1A1GLAHPGD
SCHEMBL1753026 0.67 NPC1 (0.63) KDM4EALDH1A1HPGDSMN1; SMN2MEN1
SCHEMBL10444909 0.66 KDM4E (0.71) KDM4EPKMALDH1A1GLAHPGD
SCHEMBL6088573 0.66 ALDH1A1 (0.47) KDM4EALDH1A1GLAHPGDLMNA
SCHEMBL19810277 0.66 KDM4E (0.59) KDM4EPKMALDH1A1GLAHPGD
Hydrochloric Acid SCHEMBL3034866 0.66 NPC1 (0.61) KDM4EALDH1A1HPGDSMN1; SMN2MEN1
SCHEMBL6087552 0.65 GSK3B (0.46) KDM4EALDH1A1HPGDSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7056354-B2 Compounds derived from diaminopyrazole substituted by a heteroaromatic radical and their use in oxidation dyeing of keratinous fibers L'OREAL (FR) 2006-06-06 US claimed
US-20040255397-A1 Compounds derived from diaminopyrazole substituted by a heteroaromatic radical and their use in oxidation dyeing of keratimous fibers L'OREAL (FR) 2004-12-23 US claimed
EP-1412348-A1 COMPOUNDS DERIVED FROM DIAMINOPYRAZOLE SUBSTITUTED BY A HETEROAROMATIC RADICAL AND THEIR USE IN OXIDATION DYEING OF KERATINOUS FIBRES L'OREAL (FR) 2004-04-28 EP claimed
WO-2003008405-A1 COMPOUNDS DERIVED FROM DIAMINOPYRAZOLE SUBSTITUTED BY A HETEROAROMATIC RADICAL AND THEIR USE IN OXIDATION DYEING OF KERATINOUS FIBRES L'OREAL (FR) 2003-01-30 WO claimed
US-7056354-B2 Compounds derived from diaminopyrazole substituted by a heteroaromatic radical and their use in oxidation dyeing of keratinous fibers L'OREAL (FR) 2006-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040255397-A1 Compounds derived from diaminopyrazole substituted by a heteroaromatic radical and their use in oxidation dyeing of keratimous fibers KRT18, AOC1, XRCC5 KDM4E 1495/4885PKM 396/4885ALDH1A1 85/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.